Sign in

CIK 0000072444 · Accelerated filer<br>Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
591212264
Phone
(650) 550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 8-K Event Other events
  2. 425 Deal Prospectus/Communication re Business Combination
  3. 8-K Event Other events
  4. 425 Deal Prospectus/Communication re Business Combination
  5. 425 Deal Prospectus/Communication re Business Combination
  6. DFAN14A Other Proxy Soliciting Materials
  7. DFAN14A Other Proxy Soliciting Materials
  8. DEFC14A Other DEFC14A
  9. PRRN14A Other PRRN14A
  10. SC 13D/A Stake Beneficial Ownership Report
  11. UPLOAD Other SEC-generated Letter
  12. 8-K Event Other events
  13. 425 Deal Prospectus/Communication re Business Combination
  14. 425 Deal Prospectus/Communication re Business Combination
  15. SC 13D/A Stake Beneficial Ownership Report
  16. PREC14A Other PREC14A
  17. 8-K Event Other events
  18. 425 Deal Prospectus/Communication re Business Combination
  19. 8-K Event Other events
  20. 424B3 Offering Prospectus

Page 32 of 89 · 1,773 filings